tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:6IRA Stock Latest News

IRLAB Wins Expert Backing to Advance Parkinson’s Drug Pirepemat After Positive Phase IIb Signals
Company AnnouncementsIRLAB Wins Expert Backing to Advance Parkinson’s Drug Pirepemat After Positive Phase IIb Signals
4d ago
IRLAB to Webcast Year-End 2025 Results as Parkinson’s Pipeline Advances
PremiumCompany Announcements
IRLAB to Webcast Year-End 2025 Results as Parkinson’s Pipeline Advances
6d ago
IRLAB partners with Denmark’s Biomia to apply AI-driven ISP platform to CNS drug candidates
PremiumCompany Announcements
IRLAB partners with Denmark’s Biomia to apply AI-driven ISP platform to CNS drug candidates
1M ago
IRLAB Wins Green Light for Phase Ib Trial of Novel Apathy Drug in Parkinson’s
PremiumCompany Announcements
IRLAB Wins Green Light for Phase Ib Trial of Novel Apathy Drug in Parkinson’s
2M ago
IRLAB Secures New Patent for Mesdopetam, Strengthening Market Position
PremiumCompany Announcements
IRLAB Secures New Patent for Mesdopetam, Strengthening Market Position
2M ago
IRLAB to Present at Redeye Technology & Life Science Day 2025
PremiumCompany AnnouncementsIRLAB to Present at Redeye Technology & Life Science Day 2025
3M ago
IRLAB Therapeutics Appoints Nomination Committee for 2026 AGM
Premium
Company Announcements
IRLAB Therapeutics Appoints Nomination Committee for 2026 AGM
3M ago
IRLAB’s Research Advances Highlighted at AD/PD 2026 Conference
Premium
Company Announcements
IRLAB’s Research Advances Highlighted at AD/PD 2026 Conference
4M ago
IRLAB Therapeutics Advances Drug Development with New Funding and Patent
PremiumCompany Announcements
IRLAB Therapeutics Advances Drug Development with New Funding and Patent
4M ago
IRLAB Therapeutics to Present Q3 2025 Interim Report via Webcast
PremiumCompany Announcements
IRLAB Therapeutics to Present Q3 2025 Interim Report via Webcast
4M ago
IRLAB Therapeutics Appoints New CFO to Strengthen Leadership
PremiumCompany Announcements
IRLAB Therapeutics Appoints New CFO to Strengthen Leadership
5M ago
IRLAB to Present at Redeye Neurology Event, Expanding Investor Engagement
PremiumCompany Announcements
IRLAB to Present at Redeye Neurology Event, Expanding Investor Engagement
5M ago
IRLAB Advances IRL757 for Apathy in Parkinson’s Disease with MSRD Partnership
PremiumCompany AnnouncementsIRLAB Advances IRL757 for Apathy in Parkinson’s Disease with MSRD Partnership
5M ago
IRLAB Secures Extended Patent Protection for Mesdopetam in China
Premium
Company Announcements
IRLAB Secures Extended Patent Protection for Mesdopetam in China
6M ago
IRLAB Therapeutics Increases Shares and Votes Following Rights Issue
Premium
Company Announcements
IRLAB Therapeutics Increases Shares and Votes Following Rights Issue
6M ago
IRLAB Therapeutics Strengthens Patent Portfolio and Financial Position Amid Development Progress
PremiumCompany Announcements
IRLAB Therapeutics Strengthens Patent Portfolio and Financial Position Amid Development Progress
6M ago
IRLAB Therapeutics to Present Q2 2025 Interim Report
PremiumCompany Announcements
IRLAB Therapeutics to Present Q2 2025 Interim Report
6M ago
IRLAB Therapeutics Appoints Roy Jonebrant as Interim CFO
PremiumCompany Announcements
IRLAB Therapeutics Appoints Roy Jonebrant as Interim CFO
6M ago
IRLAB Completes Rights Issue, Strengthening Financial Position
PremiumCompany Announcements
IRLAB Completes Rights Issue, Strengthening Financial Position
6M ago
IRLAB Therapeutics Announces CFO Departure Amidst Strategic Growth
PremiumCompany AnnouncementsIRLAB Therapeutics Announces CFO Departure Amidst Strategic Growth
7M ago
IRLAB Therapeutics Secures SEK 115.7 Million Through Rights Issue
Premium
Company Announcements
IRLAB Therapeutics Secures SEK 115.7 Million Through Rights Issue
7M ago
IRLAB Therapeutics Concludes Trading in Rights Issue Subscription
Premium
Company Announcements
IRLAB Therapeutics Concludes Trading in Rights Issue Subscription
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >